vs
合众银行（FSBC）与PROCEPT BioRobotics Corp（PRCT）财务数据对比。点击上方公司名可切换其他公司
PROCEPT BioRobotics Corp的季度营收约是合众银行的1.8倍（$83.1M vs $45.1M），合众银行净利率更高（41.3% vs -38.1%，领先79.3%），过去两年PROCEPT BioRobotics Corp的营收复合增速更高（24.8% vs 21.3%）
合众银行是总部设在美国明尼阿波利斯、在特拉华州注册的美国跨国银行机构，截至2025年为美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的银行。它旗下核心运营实体为美国银行全国协会，以US Bank品牌开展业务，提供银行、投资、抵押等金融服务。
PROCEPT BioRobotics是一家专注于研发和商业化泌尿外科手术机器人解决方案的医疗科技企业，其旗舰AquaBeam系统可为良性前列腺增生患者提供图像引导微创治疗，服务覆盖北美、欧洲等地区的医疗机构与患者。
FSBC vs PRCT — 直观对比
营收规模更大
PRCT
是对方的1.8倍
$45.1M
净利率更高
FSBC
高出79.3%
-38.1%
两年增速更快
PRCT
近两年复合增速
21.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $83.1M |
| 净利润 | $18.6M | $-31.6M |
| 毛利率 | — | 64.9% |
| 营业利润率 | — | -4.1% |
| 净利率 | 41.3% | -38.1% |
| 营收同比 | — | 20.2% |
| 净利润同比 | 42.0% | -27.9% |
| 每股收益（稀释后） | $0.87 | $-0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSBCPRCT
| Q1 26 | $45.1M | $83.1M | ||
| Q4 25 | $43.5M | $76.4M | ||
| Q3 25 | $41.3M | $83.3M | ||
| Q2 25 | $38.3M | $79.2M | ||
| Q1 25 | $35.3M | $69.2M | ||
| Q4 24 | $35.2M | $68.2M | ||
| Q3 24 | $31.8M | $58.4M | ||
| Q2 24 | $30.7M | $53.4M |
净利润FSBCPRCT
| Q1 26 | $18.6M | $-31.6M | ||
| Q4 25 | $17.6M | $-29.8M | ||
| Q3 25 | $16.3M | $-21.4M | ||
| Q2 25 | $14.5M | $-19.6M | ||
| Q1 25 | $13.1M | $-24.7M | ||
| Q4 24 | $13.3M | $-18.9M | ||
| Q3 24 | $10.9M | $-21.0M | ||
| Q2 24 | $10.8M | $-25.6M |
毛利率FSBCPRCT
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
营业利润率FSBCPRCT
| Q1 26 | — | -4.1% | ||
| Q4 25 | 52.9% | -40.6% | ||
| Q3 25 | 53.8% | -27.8% | ||
| Q2 25 | 52.4% | -28.0% | ||
| Q1 25 | 52.0% | -39.7% | ||
| Q4 24 | 55.1% | -28.9% | ||
| Q3 24 | 48.0% | -38.4% | ||
| Q2 24 | 49.4% | -50.3% |
净利率FSBCPRCT
| Q1 26 | 41.3% | -38.1% | ||
| Q4 25 | 40.6% | -39.1% | ||
| Q3 25 | 39.6% | -25.7% | ||
| Q2 25 | 37.9% | -24.7% | ||
| Q1 25 | 37.1% | -35.8% | ||
| Q4 24 | 37.9% | -27.6% | ||
| Q3 24 | 34.4% | -35.9% | ||
| Q2 24 | 35.2% | -48.0% |
每股收益（稀释后）FSBCPRCT
| Q1 26 | $0.87 | $-0.56 | ||
| Q4 25 | $0.83 | $-0.54 | ||
| Q3 25 | $0.77 | $-0.38 | ||
| Q2 25 | $0.68 | $-0.35 | ||
| Q1 25 | $0.62 | $-0.45 | ||
| Q4 24 | $0.61 | $-0.34 | ||
| Q3 24 | $0.52 | $-0.40 | ||
| Q2 24 | $0.51 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $644.4M | $245.6M |
| 总债务越低越好 | — | $51.7M |
| 股东权益账面价值 | $458.5M | $347.7M |
| 总资产 | $5.0B | $487.1M |
| 负债/权益比越低杠杆越低 | — | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资FSBCPRCT
| Q1 26 | $644.4M | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | — | $294.3M | ||
| Q2 25 | — | $302.7M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | — | $214.1M |
总债务FSBCPRCT
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
股东权益FSBCPRCT
| Q1 26 | $458.5M | $347.7M | ||
| Q4 25 | $445.8M | $365.9M | ||
| Q3 25 | $431.3M | $380.3M | ||
| Q2 25 | $416.7M | $385.8M | ||
| Q1 25 | $406.5M | $389.2M | ||
| Q4 24 | $396.6M | $402.2M | ||
| Q3 24 | $389.9M | $241.2M | ||
| Q2 24 | $380.5M | $251.8M |
总资产FSBCPRCT
| Q1 26 | $5.0B | $487.1M | ||
| Q4 25 | $4.8B | $508.1M | ||
| Q3 25 | $4.6B | $511.5M | ||
| Q2 25 | $4.4B | $513.1M | ||
| Q1 25 | $4.2B | $519.4M | ||
| Q4 24 | $4.1B | $534.0M | ||
| Q3 24 | $3.9B | $374.1M | ||
| Q2 24 | $3.6B | $374.4M |
负债/权益比FSBCPRCT
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FSBC
| Net Interest Income | $43.5M | 96% |
| Noninterest Income | $1.6M | 4% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
